SecBot SecBot
6-K ·Filed Oct 6, 2026

LKFT

Lakefront Biotherapeutics NV
NEUTRAL
Impact 2/10
Horizondays Processed21d ago SEC0001171843-26-006469
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine periodic disclosure of ongoing buyback execution. Monitor future 6-K filings for cumulative repurchase activity and any updates to the buyback program's size or duration.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+5d
LKFT ▼ -2.00% at T+5d
NEUTRAL call -2.00% · α vs SPY -1.02% · entry $30.00 → $29.40
Next anchor: T+20d in 7d
Latest observation: T+12 +5.48% FF3 residual α
Entry = T+0 close
Oct 6, 2026
via day close
T+1d
-1.63%
call -1.63% · α -1.21%
$29.51
settled 20d ago
T+5d
-2.00%
call -2.00% · α -1.02%
$29.40
settled 14d ago
T+20d
Pending
in 7d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Lakefront Biotherapeutics disclosed the repurchase of 117,437 ordinary shares between September 28 and October 2, 2026, at an average price of €25.99 per share, for a total consideration of approximately €3.05 million. The buyback is part of a previously announced repurchase program and is a routine capital allocation activity with no material impact on the company's fundamentals or near-term outlook.

Key Facts

  • Repurchased 117,437 shares between Sep 28 and Oct 2, 2026
  • Average price paid: €25.99 per share
  • Total consideration: €3,051,866.51
  • As of Oct 2, 2026, Lakefront holds 1,751,031 treasury shares
  • Buyback executed under a program announced on June 9, 2026

Financial Impact

Approximately €3.05 million in share repurchases over five trading days; no material impact on total shares outstanding or financial position.

shares outstandingtreasury shares

Risk Factors

  • No material risks identified from this routine buyback disclosure

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-006469
Document: f6k_100626.htm0001171843-26-006469
Document: 0001171843-26-006469-index-headers.html0001171843-26-006469
Document: 0001171843-26-006469-index.html0001171843-26-006469
Document: 0001171843-26-006469.txt0001171843-26-006469
11 reports for LKFT
Performance horizon
Filters
Rows
Reports for LKFT — sortable, filterable
TypeNow
Oct 20, 2026
7d ago
6-K
NEUTRAL ★ 2/10
$30.58awaiting T+20—$31.82 (+4.05%)
Oct 14, 2026
12d ago
6-K
NEUTRAL ★ 4/10
$29.93awaiting T+20—$31.82 (+6.31%)
Oct 13, 2026
14d ago
6-K
NEUTRAL ★ 2/10
$29.40awaiting T+20—$31.82 (+8.23%)
Oct 6, 2026
21d ago
6-K
NEUTRAL ★ 2/10
$30.00awaiting T+20—$31.82 (+6.07%)
Sep 1, 2026
8w ago
6-K
NEUTRAL ★ 2/10
$28.81 $29.65▲ +2.92%▲ +3.25%$31.82 (+10.45%)
Aug 25, 2026
9w ago
6-K
NEUTRAL ★ 4/10
$29.70 $30.72▲ +3.43%▲ +2.46%$31.82 (+7.14%)
Aug 12, 2026
10w ago
6-K
MIXED ★ 6/10
$27.93 $26.81▼ −4.01%▼ −2.11%$31.82 (+13.93%)
Jul 28, 2026
13w ago
6-K
NEUTRAL ★ 2/10
$27.72 $29.16▲ +5.19%▲ +0.17%$31.82 (+14.79%)
Jun 30, 2026
17w ago
6-K
NEUTRAL ★ 2/10
$29.60 $27.72▼ −6.35%▼ −4.17%$31.82 (+7.50%)
Jun 24, 2026
17w ago
6-K
NEUTRAL ★ 3/10
$29.01 $28.78▼ −0.79%▼ −2.73%$31.82 (+9.69%)
Showing 10 of 11

US Market Status

Market Closed — Opens Wed (16h 31m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 6, 2026